Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
2.390
+0.110 (4.82%)
Aug 22, 2025, 4:00 PM - Market closed
Adagene Market Cap
Adagene has a market cap or net worth of $112.64 million as of August 22, 2025. Its market cap has increased by 10.63% in one year.
Market Cap
112.64M
Enterprise Value
56.67M
1-Year Change
10.63%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $112.64M, a decrease of -85.99%. That is a compound annual growth rate of -35.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 112.64M | 27.86% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | 804.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |